Please assess the completion status of the following clinical trial:

Trial Title: Endoscopic Mucosal Resection and Cellular Matrix

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria~* Able to provide consent~* Scheduled for standard of care endoscopy that may require initial EMR evaluation of esophageal lesions~* Histological evidence of intestinal metaplasia with dysplasia or intramucosal carcinoma~Exclusion Criteria~* Pregnant women~* Prior esophageal EMR or ESD in the same region~* Anyone unable to provide informed consent~* Medical co-morbidities precluding EGD evaluation~* History of chemoradiotherapy to the neck/esophagus~* Unable to stop anticoagulation therapy (non-steroid anti-inflammatory medications are permissible)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Endoscopic submucosal resection with Extracelluar Matrix (Type: ACTIVE_COMPARATOR): Subjects with lesions that lift and are amenable to cap-assisted endoscopic submucosal resection (EMR) will receive extracellular matrix (ECM) to the defect site.
- Endoscopic submucosal resection standard of care (Type: NO_INTERVENTION): Subjects with lesions that lift and are amenable to cap-assisted endoscopic submucosal resection (EMR) will receive standard of care.

Based on this trial design, predict the completion outcome and termination type (if applicable).